Tempest TherapeuticsTPST
13F holders, Q3 2025 (September 30)1holders
0new positions
0sold out
$10.28avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Tempest Therapeutics Inc. (TPST) in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holder was Versant Venture Management, LLC ($2.8M).
- Company
- Tempest Therapeutics Inc.
- CUSIP
- 87978U108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Versant Venture Management, LLC | 1.31% | No change | 269,772 | $2.8M |
"% of holder's portfolio" is TPST's weight in each manager's 13F, not the share of Tempest Therapeutics Inc. the manager owns.